DVDavid Alzate Velásquez

David Alzate Velásquez

*This is an algorithmically generated author record based on publicly available information.

David Alzate Velásquez has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Splenic Lesions in Dogs: A Retrospective Epidemiological and Pathological Study

    by Hathali de Las Mercedes Sanchez Mata, Janeth Agudelo Quintero, Diego Alfonso Aranzazu Taborda, David Alzate Velásquez, Julián David Muñoz Duque

    Splenic neoplastic and non‐neoplastic lesions are frequently diagnosed in dogs and often exhibit overlapping clinical signs and gross morphological features, rendering histopathological examination essential for definitive diagnosis, therapeutic planning, and prognostic assessment. In Colombia, epidemiological data regarding these lesions remain limited, whereas international studies report considerable heterogeneity in the relative frequencies of neoplastic and non‐neoplastic conditions. This study aimed to characterize the histopathological spectrum of splenic lesions in dogs and provide updated regional epidemiological data. A retrospective analysis was conducted on splenic specimens obtained from dogs subjected to total splenectomy between January 2019 and June 2024. All samples were processed and examined histopathologically at three veterinary pathology laboratories in Medellín, Colombia. Descriptive statistical analyses were performed considering year of submission, patient demographic data, morphological diagnosis, and concurrent histopathological findings. A total of 424 cases were evaluated, of which 282 (66.5%) corresponded to non‐neoplastic lesions and 142 (33.5%) to neoplastic processes. The mean age of dogs with non‐neoplastic lesions was 9.5 (< 1–16) years, whereas dogs with neoplastic lesions had a mean age of 10.2 (4–17) years. Splenitis was the most frequent non‐neoplastic diagnosis, accounting for 54.6% of cases and demonstrating a higher prevalence than reported in prior literature. Among malignant splenic neoplasms, hemangiosarcoma was the predominant diagnosis, representing 69.2% of cases. This study demonstrates a high prevalence of non‐neoplastic splenic lesions, particularly splenitis, and a frequent occurrence of multiple concurrent morphological diagnoses in non‐neoplastic cases. These findings provide novel regional epidemiological data and contribute original information to international literature, underscoring the importance of histopathological splenic evaluation for accurate diagnosis and clinical decision‐making.

  • Open Access

    Characterization of bone marrow aspirate reports in dogs and cats: A retrospective study

    by Ingrid J Roldán-Carvajal, David Alzate-Velásquez, Julián D Muñoz-Duque, Andrés F Mesa-Oquendo, Jorge E Salazar-Flórez, Patricia E Jaramillo-Arbeláez

    Background: Bone Marrow Aspirate (BMA) allows the study, staging and monitoring of multiple conditions with bone marrow involvement. The BMA report is a crucial component of the post-analytical stage and significantly influences the veterinarian's understanding and decision-making process. Objective: To describe the zoographic, clinical, and quality characteristics of BMA reports, as well as the frequency of diagnoses and associated factors in dogs and cats treated at veterinary centers in Colombia from 2012 to 2023. Methods: This was a cross-sectional descriptive study. Data on zoographic and clinical variables were extracted from BMA reports and consultations; the frequency of diagnoses and associated factors were determined. Adherence to reporting quality was evaluated using established guidelines for BMA in dogs, cats, and humans. Results: A total of 135 BMA reports were reviewed from eight veterinary institutions: 116 for dogs and 19 for cats, with a mean age of 5.22 ± 3 years; 53% were males. The most common indication for BMA was anemia, alone or with other abnormalities. The least adhered-to reporting elements were puncture site (91.9%), relevant clinical data (85.2%), and morphological evaluation by cell line (52.6%). Additionally, 27.4% of the reports were excluded due to poor sample quality. The most frequent diagnosis in dogs was hypoplasia (36.1%), while in cats, it was neoplasia (40.0%). Erythroid hyperplasia and neoplasms were more prevalent in males, whereas granulocytic hypoplasia was more common in females. Conclusions: BMA as a diagnostic tool in dogs and cats in Colombia is rare. A significant proportion of samples did not meet quality criteria, and there was low adherence to reporting guidelines.


  • Open Access

    Indicaciones para la evaluación morfológica de la médula ósea en caninos y felinos: revisión de la literatura

    by I. J. Roldán–Carvajal, P. E. Jaramillo–Arbeláez, D. A. Velásquez, J. D. Muñoz–Duque

    Son múltiples las indicaciones para evaluar la médula ósea de caninos o felinos, entre ellas, anomalías persistentes o de causa no explicable, alteraciones en el hemograma y/o en la bioquímica sanguínea, acompañadas de signos y síntomas que pueden ser inespecíficos, estos pueden ser trastornos reactivos o de origen medular. El objetivo de esta revisión es presentar un panorama general de las indicaciones más frecuentes para la evaluación morfológica de la médula ósea en caninos y felinos y hallazgos reportados en la literatura. Como metodología, se empleó un abordaje de los trastornos malignos y benignos con compromiso medular en caninos y felinos, mediante una búsqueda de artículos originales en las bases de datos PubMed, ScienceDirect, Scopus, SciELO y LILACS, en la que se utilizaron los términos MeSh: bone marrow neoplasms, bone marrow examination, congenital bone marrow failure syndromes, bone marrow failure disorders, combinados con el operador booleano AND con las palabras dog y cat. Se encontraron artículos que estudiaron la médula ósea para el diagnóstico diferencial de infecciones como leishmaniasis, ehrlichiosis y anaplasmosis. Sin embargo, en su mayoría, las publicaciones tenían como objetivo el diagnóstico de procesos malignos, como trastornos mieloproliferativos y linfoproliferativos. Se concluye que la evaluación de la médula ósea es de gran importancia, lo que permite esclarecer diagnósticos y evaluar la estadificación de algunas enfermedades, así como su pronóstico y seguimiento. There are multiple indications to evaluate the bone marrow in canines and felines, persistent or unexplained abnormalities in the blood count and serum biochemistry, accompanied by non-specific signs and symptoms. They can be reactive or marrow disorders. The objective was to present an overview of the most frequent indications for the morphological evaluation of bone marrow in canines and felines reported in the literature. An approach was made to malignant and benign disorders with bone marrow involvement in canines and felines and the frequency is presented through a search of original articles in the databases PubMed, ScienceDirect, Scopus, SciELO, and LILACS, using MeSh terms: bone marrow neoplasms, bone marrow examination, congenital bone marrow failure syndromes, bone marrow failure disorders, combined with the Boolean operator AND with the words dog and cat. Articles that applied bone marrow as an aid for the differential diagnosis of infections such as leishmaniasis, ehrlichiosis and anaplasmosis were found. However, most of the publications are aimed at diagnosing malignant processes, such as myeloproliferative and lymphoproliferative disorders. It is concluded that the evaluation of the bone marrow is of great importance, resulting in clarifying the diagnosis and evaluating the staging of some diseases, as well as their prognosis and follow-up.